Core Viewpoint - The article discusses the best Real Estate Investment Trusts (REITs) to consider for investment as February 2026 approaches, starting with the lowest to the highest yielders [1]. Group 1: Company Analysis - Invitation Homes (INVH) is highlighted as one of the REITs under consideration for investment [1].

Boston, Massachusetts--(Newsfile Corp. - February 2, 2026) - Paul J. Scott, Founder and Chief B2B Website Strategist at B2B web design and development agency, GoingClear, recently shared his expertise on B2B growth leadership and HubSpot CMS in an in-depth interview with DesignRush.GoingClear Founder and Chief B2B Website Strategist, Paul J. ScottTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10587/282359_36ddd2e194719a55_001full.jpgIn the interview, Scott e ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

Group 1 - The article highlights the significant rise in precious metals due to increasing geopolitical tensions, a continuous decline of the U.S. dollar, inflation fears, rising national debt, and tariffs creating market uncertainty [1]

Core Viewpoint - Nvidia's stock is experiencing a decline due to uncertainties surrounding its $100 billion investment in OpenAI, the developer of ChatGPT [1] Group 1: Nvidia's Investment in OpenAI - Nvidia is recognized as the leading provider of artificial intelligence chips, which positions the company strategically in the AI market [1] - The commitment to a significant investment in OpenAI is now being questioned, raising concerns about Nvidia's future financial performance [1]

Core Insights - The article discusses the author's long-term investment approach, focusing on REITs, preferred stocks, and high-yield bonds, which began in high school in 2011 [1] - The author has recently combined long stock positions with covered calls and cash secured puts, indicating a strategic evolution in investment tactics [1] - The primary focus of the author's analysis on Seeking Alpha includes REITs and financials, with occasional insights on ETFs and macro-driven stock ideas [1] Investment Strategy - The investment strategy is fundamentally long-term, emphasizing a deep understanding of market dynamics and economic factors [1] - The author employs a combination of long positions and options strategies to enhance returns and manage risk [1] Coverage Focus - The author primarily covers REITs and financial sectors, suggesting a specialization that may provide deeper insights into these areas [1] - Occasional articles on ETFs and other stocks driven by macroeconomic trends indicate a broader market awareness and adaptability [1]

I ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets and the economy that has not faded despite the years. More recently I have been combining long stock positions with covered calls and cash secured puts. I approach investing purely from a fundamental long-term point of view. On Seeking Alpha I mostly cover REITs and financials, with occasional articles on ETFs and other stocks driven by a macro trade idea.Analyst’s D ...

Core Viewpoint - Northern Graphite Corporation, along with partners, has launched the USE-G initiative to develop environmentally friendly graphite extraction technologies for Europe's battery industry, funded primarily by the German Federal Ministry for Economic Affairs and Energy [1][2][8] Group 1: Project Overview - The USE-G initiative aims to create new graphite processing technologies that are cleaner, less energy-intensive, and independent of Chinese supply chains, with a total project budget of €1.70 million, of which €1.14 million is contributed by the Ministry [2][3] - The project will focus on the purification of natural graphite without hydrofluoric acid, the development of sustainable coating materials, and the recovery of graphite from battery recycling [3][5] Group 2: Roles and Contributions - Northern Graphite will supply natural graphite from its Canadian mine and potentially from its Namibian mine, and will conduct milling, shaping, and battery testing in Germany [4][6] - H.C. Starck Tungsten will provide technology to extract graphite from spent lithium-ion batteries, enabling the recycling of materials typically lost in conventional processes [4][9] - Friedrich Schiller University Jena will lead the development of a novel chlorine gas purification method, which is cleaner and less energy-intensive than current methods [5][9] Group 3: Goals and Timeline - The project will initially process natural and recycled graphite separately to establish performance and purity benchmarks, followed by evaluations for blending these materials into a unified anode product [6][9] - The USE-G program commenced on January 1, 2026, and will run until December 31, 2029, aiming to demonstrate a complete European-controlled graphite processing flow sheet by the end of the program [9]

Company Retains Ludlow Consulting to Elevate Institutional-Grade Messaging, Media Relations and AI-Enabled Investor Engagement SUNNY ISLES BEACH, FLORIDA / ACCESS Newswire / February 2, 2026 / Elektros Inc. (OTC PINK:ELEK), a hard-rock lithium mining developer with operations in Sierra Leone, today announced it has retained Ludlow Consulting as its strategic communications advisor to enhance corporate messaging, media visibility, and shareholder engagement. The Company believes the current market environmen ...

Core Insights - TuHURA Biosciences, Inc. has received Orphan Drug Designation from the FDA for its product IFx-2.0, aimed at treating stage IIB to stage IV cutaneous melanoma [1][3] - The designation is based on positive results from a Phase 1 study, which indicated that IFx-Hu2.0 is safe and provides clinical benefits to patients who are refractory to checkpoint inhibitor therapy [2] - The company is currently focused on completing enrollment for a Phase 3 study of IFx-2.0 in combination with Keytruda® for advanced or metastatic Merkel Cell Carcinoma [3] Company Overview - TuHURA Biosciences is a Phase 3 immuno-oncology company that develops novel therapeutics to address resistance to cancer immunotherapy [4] - The lead product, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors and is being tested in a randomized Phase 3 trial [5] - The company has also acquired TBS-2025, which is moving into Phase 2 development for mutNPM1 r/r AML, and is developing bi-specific antibody drug conjugates targeting immune-suppressing cells in the tumor microenvironment [6]